- |||||||||| LYN-00101 / Lynkcell
Enrollment closed, Enrollment change: Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101 (clinicaltrials.gov) - Apr 29, 2019 P1, N=19, Active, not recruiting, N=19 --> 0 | Trial completion date: Feb 2020 --> Aug 2020 | Active, not recruiting --> Withdrawn | Trial primary completion date: Nov 2019 --> Jun 2020 Recruiting --> Active, not recruiting | N=37 --> 19
- |||||||||| LYN-00101 / Lynkcell
Enrollment open, Trial completion date, Trial initiation date, Trial primary completion date: Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101 (clinicaltrials.gov) - Apr 4, 2019 P1, N=37, Recruiting, Recruiting --> Active, not recruiting | N=37 --> 19 Not yet recruiting --> Recruiting | Trial completion date: Jul 2019 --> Feb 2020 | Initiation date: Oct 2018 --> Apr 2019 | Trial primary completion date: Apr 2019 --> Nov 2019
|